People
A new poll shows nearly two-thirds of people blame the pharmaceutical companies for the opioid crisis.
Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds J. David Warren, Ph.D., to its Scientific Advisory Board.
DCprime announced the appointment of two highly-experienced industry veterans, Andrea van Elsas, Ph.D. and Hans Preusting, Ph.D., M.B.A, to its Supervisory Board.
Young Entrepreneur Council is an invitation-only community for the world’s most successful entrepreneurs.
David Wilkinson brings experience of strategy & governance in growth firms
Companies strengthen leadership teams with C-suite and boards of directors appointments, with new hires at Sandoz, Mission Bio, SkinBio, Epic Sciences, and more.
The employees were terminated over allegations of industrial espionage on behalf of the Chinese government. MD Anderson ought to quell concerns of racial profiling following the firings.
Turf cutting for the Bellhouse Building to be performed by Lord & Lady Drayson
Accenture recently published a new report, “New Science: Biopharma’s New Growth Machine.” In it, the report attempts to evaluate the last 20 years of trends in biopharma and use that data to develop projections for the future of the industry.
For the past nine years, Saynor has been with GSK, most recently serving as senior vice president and global head of classic and established medicines.
PRESS RELEASES